|
11 Companies |
|
15 Products |
|
15 Products |
|
21 Mechanisms of Action |
|
0 Trials |
|
119 News |
|
| 123» |
- | Trial completion date: Physiotherapy for Radiation-induced Trismus (clinicaltrials.gov) - Jan 5, 2019
P=N/A, N=90, Completed, Sponsor: Federal University of Health Science of Porto Alegre
Trial completion date: Jul 2014 --> Jun 2017
- | Trial completion, Trial completion date: EPGP: Epilepsy Phenome/Genome Project (clinicaltrials.gov) - Nov 13, 2018
P=N/A, N=4150, Completed, Sponsor: University of California, San Francisco
Trial completion date: Jul 2014 --> Jun 2017 Active, not recruiting --> Completed | Trial completion date: Apr 2014 --> Oct 2018
- | Trial completion: Botulinum Toxin Injection in Hypercontractile Esophagus (clinicaltrials.gov) - Jun 1, 2018
P2, N=24, Completed, Sponsor: Hospices Civils de Lyon
Active, not recruiting --> Completed | Trial completion date: Apr 2014 --> Oct 2018 Active, not recruiting --> Completed
- | vigabatrin / Generic mfg.
Trial completion: SoluWest: Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy (clinicaltrials.gov) - Apr 24, 2018
P=N/A, N=38, Completed, Sponsor: Targeon SAS
Active, not recruiting --> Completed Recruiting --> Completed
- | Trial completion, Enrollment change: Evaluation of Neuroinflammation in Children With Infantile Spasms (clinicaltrials.gov) - Nov 7, 2017
P4, N=8, Completed, Sponsor: Wayne State University
Recruiting --> Completed Recruiting --> Completed | N=10 --> 8
- | diazepam / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Vaginal Diazepam for the Treatment of Female Pelvic Pain (clinicaltrials.gov) - Jul 26, 2017
P2, N=50, Completed, Sponsor: University of Missouri-Columbia
Recruiting --> Completed | N=10 --> 8 Active, not recruiting --> Completed | N=37 --> 50 | Trial primary completion date: Jun 2017 --> Mar 2017
- | dextromethorphan / Generic mfg.
Trial completion: Dextromethorphan to Treat Patients With Voice Spasms (clinicaltrials.gov) - Jun 30, 2017
P1, N=65, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Active, not recruiting --> Completed | N=37 --> 50 | Trial primary completion date: Jun 2017 --> Mar 2017 Recruiting --> Completed
- | Enrollment closed: Botulinum Toxin Injection in Hypercontractile Esophagus (clinicaltrials.gov) - May 31, 2017
P2, N=24, Active, not recruiting, Sponsor: Hospices Civils de Lyon
Recruiting --> Completed Recruiting --> Active, not recruiting
- | Erivedge (vismodegib) / Roche
Trial completion: Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms (clinicaltrials.gov) - May 31, 2017
P=N/A, N=12, Completed, Sponsor: Stanford University
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Trial completion, Phase classification, Enrollment change, Trial primary completion date: Per-Oral Endoscopic Myotomy (P.O.E.M.) for Treatment of Esophageal Motility Disorders (clinicaltrials.gov) - May 1, 2017
P=N/A, N=50, Completed, Sponsor: Chinese University of Hong Kong
Active, not recruiting --> Completed Recruiting --> Completed | Phase classification: P1/2 --> PN/A | N=20 --> 50 | Trial primary completion date: Dec 2015 --> Apr 2017
- Erivedge (vismodegib) / Roche
Enrollment closed, Enrollment change: Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms (clinicaltrials.gov) - Oct 26, 2016
P=N/A, N=11, Active, not recruiting, Sponsor: Stanford University
Recruiting --> Completed | Phase classification: P1/2 --> PN/A | N=20 --> 50 | Trial primary completion date: Dec 2015 --> Apr 2017 Recruiting --> Active, not recruiting | N=26 --> 11
- |||| fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg.
Trial completion: A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise (clinicaltrials.gov) - Sep 22, 2016
P4, N=255, Completed, Sponsor: GlaxoSmithKline
Recruiting --> Active, not recruiting | N=26 --> 11 No longer recruiting --> Completed
- |||| fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg.
Trial completion: A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise (clinicaltrials.gov) - Sep 22, 2016
P4, N=227, Completed, Sponsor: GlaxoSmithKline
No longer recruiting --> Completed No longer recruiting --> Completed
- Enrollment change, Trial termination: Preoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent Pain (clinicaltrials.gov) - Sep 6, 2016
P=N/A, N=3, Terminated, Sponsor: University of Missouri-Columbia
N=30 --> 3 | Recruiting --> Terminated; Co-Investigator left institution. No data analysis occurred.
- diazepam / Generic mfg.
Enrollment closed, Enrollment change, Trial primary completion date: Vaginal Diazepam for the Treatment of Female Pelvic Pain (clinicaltrials.gov) - Aug 4, 2016
P2, N=37, Active, not recruiting, Sponsor: University of Missouri-Columbia
No data analysis occurred. Recruiting --> Active, not recruiting | N=50 --> 37 | Trial primary completion date: Jun 2016 --> Jun 2017
- ||| vigabatrin / Generic mfg.
Trial completion, Enrollment change: Sabril Patient Registry (clinicaltrials.gov) - Jul 30, 2016
P=N/A, N=9423, Completed, Sponsor: Lundbeck LLC
Recruiting --> Active, not recruiting | N=50 --> 37 | Trial primary completion date: Jun 2016 --> Jun 2017 Enrolling by invitation --> Completed | N=15000 --> 9423
- Trial completion, Trial primary completion date: Ultrasound Guided Pudendal Block in Transurethral Prostatectomies (clinicaltrials.gov) - Jun 14, 2016
P=N/A, N=40, Completed, Sponsor: Diskapi Teaching and Research Hospital
Enrolling by invitation --> Completed | N=15000 --> 9423 Recruiting --> Completed | Trial primary completion date: May 2012 --> Apr 2013
- ||| Trial completion: Diagnosis of Exercise-induced Bronchospasm (EIB) and Asthma in National Collegiate Athletic Association (NCAA) Division I Athletes (clinicaltrials.gov) - May 13, 2016
P=N/A, N=74, Completed, Sponsor: University of Arizona
Recruiting --> Completed | Trial primary completion date: May 2012 --> Apr 2013 Recruiting --> Completed
- Erivedge (vismodegib) / Roche
Trial primary completion date: Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms (clinicaltrials.gov) - Apr 9, 2016
P=N/A, N=26, Recruiting, Sponsor: Stanford University
Recruiting --> Completed Trial primary completion date: Dec 2015 --> Mar 2017
- Trial primary completion date: Botulinum Toxin Injection in Hypercontractile Esophagus (clinicaltrials.gov) - Mar 11, 2016
P2, N=28, Recruiting, Sponsor: Hospices Civils de Lyon
Trial primary completion date: Dec 2015 --> Mar 2017 Trial primary completion date: May 2016 --> May 2017
- Enrollment change, Trial termination: Energy Costs of Spasticity in Spinal Cord Injury: A Pilot Investigation (clinicaltrials.gov) - Feb 24, 2016
P=N/A, N=20, Terminated, Sponsor: Virginia Commonwealth University
Trial primary completion date: May 2016 --> May 2017 N=36 --> 20 | Recruiting --> Terminated; Unable to recruit enough participants.
- amikacin sulfate / Generic mfg.
Trial completion, Enrollment change: NIV-NEBU: Pharmacokinetics of Nebulized Amikacin in Non Invasive Ventilated Healthy Volunteers. (clinicaltrials.gov) - Feb 2, 2016
P=N/A, N=7, Completed, Sponsor: University Hospital St Luc, Brussels
N=36 --> 20 | Recruiting --> Terminated; Unable to recruit enough participants. Recruiting --> Completed | N=10 --> 7
- Trial primary completion date: Evaluation of Neuroinflammation in Children With Infantile Spasms (clinicaltrials.gov) - Jan 17, 2016
P4, N=10, Recruiting, Sponsor: Wayne State University
Recruiting --> Completed | N=10 --> 7 Trial primary completion date: Jul 2015 --> Jul 2016
- Trial completion, Trial primary completion date: Coronary Spasm Presenting Aborted Sudden Cardiac Death, the Multicenter Registry (clinicaltrials.gov) - Dec 30, 2015
P=N/A, N=200, Completed, Sponsor: Seung-Jung Park
Trial primary completion date: Jul 2015 --> Jul 2016 Recruiting --> Completed | Trial primary completion date: Mar 2015 --> Sep 2015
- arformoterol / Generic mfg.
Enrollment change, Trial withdrawal: Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB) (clinicaltrials.gov) - Dec 12, 2015
P3, N=0, Withdrawn, Sponsor: University of New Mexico
Recruiting --> Completed | Trial primary completion date: Mar 2015 --> Sep 2015 N=20 --> 0 | Terminated --> Withdrawn
- diazepam / Generic mfg.
Trial primary completion date: Vaginal Diazepam for the Treatment of Female Pelvic Pain (clinicaltrials.gov) - Dec 5, 2015
P2, N=50, Recruiting, Sponsor: University of Missouri-Columbia
N=20 --> 0 | Terminated --> Withdrawn Trial primary completion date: Aug 2015 --> Jun 2016
- Trial completion: Lp-PLA2 and Coronary Atherosclerosis in Humans (clinicaltrials.gov) - Sep 25, 2015
P=N/A, N=166, Completed, Sponsor: Mayo Clinic
Trial primary completion date: Aug 2015 --> Jun 2016 Recruiting --> Completed
- Trial completion: Trismus Trial of Therabite vs Wooden Spatula in Head and Neck Cancer Patients (clinicaltrials.gov) - Aug 14, 2015
P2, N=71, Completed, Sponsor: Colin Lunt
Recruiting --> Completed Active, not recruiting --> Completed
- amikacin sulfate / Generic mfg.
Trial primary completion date: NIV-NEBU: Pharmacokinetics of Nebulized Amikacin in Non Invasive Ventilated Healthy Volunteers. (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=10, Recruiting, Sponsor: University Hospital St Luc, Brussels
Active, not recruiting --> Completed Trial primary completion date: Feb 2015 --> Jun 2015
- Enrollment change, Trial withdrawal: CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=0, Withdrawn, Sponsor: St. Olavs Hospital
Trial primary completion date: Feb 2015 --> Jun 2015 N=400 --> 0 | Active, not recruiting --> Withdrawn
- Enrollment change: Trismus Trial of Therabite vs Wooden Spatula in Head and Neck Cancer Patients (clinicaltrials.gov) - Jun 11, 2015
P2, N=71, Active, not recruiting, Sponsor: Colin Lunt
N=400 --> 0 | Active, not recruiting --> Withdrawn N=112 --> 71
- azithromycin / Generic mfg.
Trial completion, Enrollment change: Effect of Azithromycin on Oesophageal Hypomotility (clinicaltrials.gov) - Apr 22, 2015
P2, N=26, Completed, Sponsor: JAFAR JAFARI
N=112 --> 71 Not yet recruiting --> Completed | N=34 --> 26
- Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
Trial completion, Enrollment change, Trial primary completion date: VginsmsBOTOX: Injection of Botox in the Perineal Muscles in Resistant Cases of Vaginal Spasm (clinicaltrials.gov) - Apr 14, 2015
P=N/A, N=32, Completed, Sponsor: Abdel-Maguid Ramzy
Not yet recruiting --> Completed | N=34 --> 26 Recruiting --> Completed | N=20 --> 32 | Trial primary completion date: Dec 2013 --> Mar 2014
- Trial completion: Physiotherapy for Radiation-induced Trismus (clinicaltrials.gov) - Mar 19, 2015
P=N/A, N=90, Completed, Sponsor: Federal University of Health Science of Porto Alegre
Recruiting --> Completed | N=20 --> 32 | Trial primary completion date: Dec 2013 --> Mar 2014 Recruiting --> Completed
- ||||||| Trial completion: Efficacy of Buscopan® in Comparison With 654-II (Anisodamine) in Acute Gastric or Intestinal Pain (clinicaltrials.gov) - Mar 10, 2015
P3, N=299, Completed, Sponsor: Boehringer Ingelheim
Recruiting --> Completed Recruiting --> Completed
- Trial completion, Enrollment change: Topical Bethanechol for Improvement of Esophageal Dysmotility (clinicaltrials.gov) - Jan 29, 2015
P1, N=5, Completed, Sponsor: Georgia Regents University
Recruiting --> Completed Recruiting --> Completed | N=10 --> 5
- Erivedge (vismodegib) / Roche
Trial primary completion date: Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms (clinicaltrials.gov) - Jan 26, 2015
P=N/A, N=26, Recruiting, Sponsor: Stanford University
Recruiting --> Completed | N=10 --> 5 Trial primary completion date: Dec 2014 --> Dec 2015
- Enrollment closed: Trismus Trial of Therabite vs Wooden Spatula in Head and Neck Cancer Patients (clinicaltrials.gov) - Jan 22, 2015
P2, N=112, Active, not recruiting, Sponsor: Colin Lunt
Trial primary completion date: Dec 2014 --> Dec 2015 Recruiting --> Active, not recruiting
- Trial primary completion date: Botulinum Toxin Injection in Hypercontractile Esophagus (clinicaltrials.gov) - Jan 18, 2015
P2, N=28, Recruiting, Sponsor: Hospices Civils de Lyon
Recruiting --> Active, not recruiting Trial primary completion date: May 2015 --> May 2016
- diazepam / Generic mfg.
Trial primary completion date: Vaginal Diazepam for the Treatment of Female Pelvic Pain (clinicaltrials.gov) - Dec 10, 2014
P2, N=50, Recruiting, Sponsor: University of Missouri-Columbia
Trial primary completion date: May 2015 --> May 2016 Trial primary completion date: Aug 2014 --> Aug 2015
- amikacin sulfate / Generic mfg.
Trial primary completion date: NIV-NEBU: Pharmacokinetics of Nebulized Amikacin in Non Invasive Ventilated Healthy Volunteers. (clinicaltrials.gov) - Dec 6, 2014
P=N/A, N=10, Recruiting, Sponsor: University Hospital St Luc, Brussels
Trial primary completion date: Aug 2014 --> Aug 2015 Trial primary completion date: Oct 2014 --> Feb 2015
- Clinical: Coronary Spasm Presenting Aborted Sudden Cardiac Death, the Multicenter Registry (clinicaltrials.gov) - Nov 24, 2014
P=N/A, N=200, Recruiting, Sponsor: Seung-Jung Park
- baclofen / Generic mfg.
New P2 trial: Safety and Efficacy of Baclofen for Treatment of Muscle Spasms in Patients With Cirrhosis: A Pilot Study (clinicaltrials.gov) - Nov 24, 2014
P2, N=10, Completed, Sponsor: University of Virginia
- nitroglycerin / Generic mfg.
Trial completion: Prevention and Comparison of Different Forms of Administration of Nitrates in the Risk of Radial Spasm During Coronary Angiography. (clinicaltrials.gov) - Oct 11, 2014
P=N/A, N=442, Completed, Sponsor: Brugmann University Hospital
Trial primary completion date: Oct 2014 --> Feb 2015 Not yet recruiting --> Completed
- |||||||||| hyoscine butylbromide oral / Generic mfg.
New P3 trial: Study to Evaluate the Efficacy and Safety of Hyoscine Butylbromide Tablets for the Treatment of Occasional or Recurrent Episodes of Gastric or Intestinal Spasm-like Pain or Discomfort (clinicaltrials.gov) - Sep 19, 2014
P3, N=302, Completed, Sponsor: Boehringer Ingelheim
- Trial primary completion date: Per-Oral Endoscopic Myotomy (P.O.E.M.) for Treatment of Esophageal Motility Disorders (clinicaltrials.gov) - Sep 8, 2014
P1/2, N=20, Recruiting, Sponsor: Chinese University of Hong Kong
Not yet recruiting --> Completed Trial primary completion date: Feb 2012 --> Dec 2015
- ||||| hyoscine butylbromide/paracetamol / Generic mfg., paracetamol / Generic mfg.
New P2 trial: Efficacy and Tolerability of Buscopan Plus in Painful Gastric or Intestinal Spasms (clinicaltrials.gov) - Sep 4, 2014
P2, N=1637, Completed, Sponsor: Boehringer Ingelheim
- || Trial primary completion date: Lp-PLA2 and Coronary Atherosclerosis in Humans (clinicaltrials.gov) - Aug 21, 2014
P=N/A, N=200, Recruiting, Sponsor: Mayo Clinic
Trial primary completion date: Feb 2012 --> Dec 2015 Trial primary completion date: Jan 2015 --> Apr 2015
- vigabatrin / Generic mfg.
Clinical: SoluWest: Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy (clinicaltrials.gov) - Aug 19, 2014
P=N/A, N=50, Recruiting, Sponsor: Targeon SAS
- |||| Trial primary completion date: Efficacy of Buscopan® in Comparison With 654-II (Anisodamine) in Acute Gastric or Intestinal Pain (clinicaltrials.gov) - Aug 7, 2014
P3, N=296, Recruiting, Sponsor: Boehringer Ingelheim
Trial primary completion date: Jan 2015 --> Apr 2015 Trial primary completion date: Sep 2014 --> Mar 2015